Smaller portions, more protein: How GLP-1s are quietly changing chain restaurant menus [MSNBC.com]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: MSNBC.com
AsGLP-1 medicationsOnce exclusively a treatment for diabetes, GLP-1 drugs such as Zepbound and Wegovy, which suppress appetite and slow digestion, have become amainstream weight-loss toolSmoothie King is among the restaurants that capitalized on this movement as early as 2024, introducing a GLP-1 menu featuring smoothies with high protein and fiber content, andwith zero grams of added sugar.Olive Gardenannounced in Decemberhigh-protein menuGood Fit MenuThis month, Subway added “Protein Pockets,For those taking GLP-1s, eating higher-protein foods goes hand in hand with eating smaller portions. The medications severely curb users’ appetites, so when they do eat, they need nutrient-rich foods to ensure they are still eating a balanced meal. Protein also keeps you fuller for longer, so eating foods packed with protein helps with weight loss, as you do not have to eat as frequently or as much.But even if only some of these restaurants explicitly state that these medications — and their cus
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Lilly's sofetabart mipitecan receives U.S. FDA's Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancerPR Newswire
- Prediction: 2026 Will Be the Year of Eli Lilly [Yahoo! Finance]Yahoo! Finance
- What Eli Lilly (LLY)'s NVIDIA AI Lab And Obesity Data Reveal About Its Obesity Leadership Narrative [Yahoo! Finance]Yahoo! Finance
- Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026? [Yahoo! Finance]Yahoo! Finance
- BMO Reaffirms Eli Lilly and Company (LLY) as an Obesity Market Leader [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 10/30/25 - Beat
LLY
Sec Filings
- 1/8/26 - Form 4
- 1/6/26 - Form 3
- 1/6/26 - Form 4
- LLY's page on the SEC website